Ash focuses on investing across the UK in early and growth-stage companies in the Life Sciences & Biosciences sector. Additionally he advises on relevant transactions across the Group's funds. He serves as a non-executive director to portfolio companies applying a broad range of technologies to solve problems in human and animal health.
Prior to joining Mercia, Ash was the clinical technology director at Babylon Health where he helped to build a multi-award winning medical technology platform which secured Europe's largest ever Series A investment in digital health ($25.0million). He is also an anaesthetics and critical care doctor, having trained at the Imperial School of Anaesthesia. Ash holds an MA in Medical Sciences and a BMBCh Medical Degree from the University of Oxford, and he is a member of both the Royal College of Anaesthetists and the CFA Institute, UK.